Skip to main content

1 Result(s)

within Hajime Senjo Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan

    Tisagenlecleucel, an autologous CD19-directed T-cell immunotherapy, can induce a durable response in adult patients with relapsed/refractory (r/r) B-cell lymphoma.

    Hideki Goto, Toshio Kitawaki, Nobuharu Fujii… in International Journal of Clinical Oncology (2023)